GAVIPLAS, S.L.

Their core work

GAVIPLAS is a Spanish plastics manufacturing SME specializing in flexible packaging for food and pharmaceutical markets. Their core value in EU research consortia is industrial know-how: they bring real production processes and manufacturing constraints to projects that otherwise risk staying at lab scale. In AgriMax they contributed packaging expertise to a biorefinery chain turning agricultural waste into useful materials; in MANDALA they are directly tackling the transition of existing multilayer plastic packaging toward recyclable, biodegradable, or single-polymer alternatives. In plain terms, they make plastic packaging and are actively working to make it less of an environmental problem.

What they specialise in

How they've shifted over time

In their first H2020 project (AgriMax, 2016-2021), GAVIPLAS was involved at the upstream end: how to extract and process agricultural and food processing waste using ultrasound, solvent extraction, filtration, and enzymatic treatment to create materials useful for packaging. The emphasis was on the supply side — what comes in to make packaging. By their second project (MANDALA, 2019-2023), the focus shifted sharply to the packaging product itself: making multilayer plastic structures recyclable or replaceable with monolayer or single-polymer formats, using biobased adhesives and biodegradable materials. The trajectory is clear: from "what can we make packaging from" to "how do we redesign packaging to close the loop."

GAVIPLAS is moving toward circular packaging design — specifically the technical challenge of replacing hard-to-recycle multilayer plastics with mono-material or biobased alternatives — which positions them well for future EU projects targeting plastic waste reduction and packaging regulation compliance.

How they like to work

GAVIPLAS has never led an H2020 project — they join as a participant every time, which is typical for industrial SMEs that contribute manufacturing expertise and real-world testing capacity rather than research leadership. Despite only two projects, they have accumulated 43 unique consortium partners across 13 countries, which means they work in large, multi-partner consortia rather than small bilateral collaborations. This suggests they are comfortable operating as one industrial node in a complex network, likely contributing pilot-scale testing, end-user validation, or market feedback rather than driving the research agenda.

With 43 unique partners across 13 countries from just two projects, GAVIPLAS has a surprisingly broad European network for a micro-SME. Their reach is genuinely pan-European rather than regionally clustered, which is typical of large Horizon consortia where packaging SMEs are recruited as industrial end-users or pilot-plant operators.

What sets them apart

GAVIPLAS occupies a specific niche that is hard to fill in research consortia: an actual plastic packaging manufacturer willing to participate in EU research, test new materials in production-relevant conditions, and provide grounded industry feedback on what is commercially viable. Most packaging research lacks this anchor, making companies like GAVIPLAS valuable as the "reality check" partner. Their dual focus on food and pharma packaging also makes them relevant for consortia that need to demonstrate regulatory-grade applications.

Highlights from their portfolio

• MANDALA
  Their largest project by funding (EUR 289,022) and the one most directly aligned with current EU packaging regulation pressure — targeting the replacement of non-recyclable multilayer plastics with biobased, compostable, or single-polymer alternatives for both food and pharma markets.
• AgriMax
  Demonstrates an earlier, upstream capability: contributing packaging industry expertise to a multi-feedstock biorefinery project, showing they can engage with materials science at the supply chain level, not just the final product.